UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 million people around the world. About 80 percent of people with MS experience inflammation in the cerebellum, the part of the brain that controls movement and balance. This can lead to tremors, poor coordination, and difficulty with […]



Summary

A UC Riverside study offers hope for new multiple sclerosis (MS) treatments by focusing on cerebellar inflammation. Affecting 2.3 million globally, MS often manifests with inflammation in the cerebellum, leading to motor control issues like tremors and poor coordination in 80% of patients. The research investigates the specific mechanisms behind this inflammation, aiming to identify potential drug targets to reduce cerebellar damage and improve motor function for those suffering from MS. This research may lead to treatments that improve quality of life for MS patients.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!